Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of Adalimumab for Nail Psoriasis in Chronic Plaque Psoriasis
2013-003275-36Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Jan 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in nail psoriasis and psoriasis comparing Adalimumab with Placebo (2 arms). Started Jan 2014; status: completed.
02
Drugs
03
Conditions
nail psoriasispsoriasis
Beyond the preview
Go deeper on 2013-003275-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003275-36.